Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: A cross-sectional study

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Sekita, Atsuko ^a   Arima, Hisatomi ^a   Ninomiya, Toshiharu ^a   Ohara, Tomoyuki ^a   Doi, Yasufumi ^a   Hirakawa, Yoichiro ^a   Fukuhara, Masayo ^a   Hata, Jun ^a   Yonemoto, Koji ^b   Ga, Yukiko ^a   Kitazono, Takanari ^a   Kanba, Shigenobu ^a   Kiyohara, Yutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Depressive symptoms; Japanese; Metabolic syndrome; Population based

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CROSS-SECTIONAL STUDY; DEPRESSIVE DISORDER; FEMALE; HUMAN; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEX DIFFERENCE; STATISTICAL MODEL; WAIST CIRCUMFERENCE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84884186550     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-862     Document Type: Article

References (39)

1. Murray CJL, Lopez AP, Global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 Cambridge: Harvard University Press 1996
2. No health without mental health. Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A, Lancet 2007 370 859 877 10.1016/S0140-6736(07) 61238-0 17804063 (Pubitemid 47371145)
3. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB, Diabetes Care 2012 35 1171 1180 10.2337/dc11-2055 22517938
4. Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama study. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Nomiyama K, Ohmori S, Yoshitake T, Shinkawu A, et al. Diabetologia 1993 36 1198 1203 10.1007/BF00401066 8270136 (Pubitemid 23314572)
5. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y, Arterioscler Thromb Vasc Biol 2008 28 1385 1391 10.1161/ATVBAHA.107.157164 18403728
6. Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama study. Sekita A, Ninomiya T, Tanizaki Y, Doi Y, Hata J, Yonemoto K, Arima H, Sasaki K, Iida M, Iwaki T, et al. Acta Psychiatr Scand 2010 122 319 325 10.1111/j.1600-0447.2010.01587.x 20626720
7. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
8. The CES-D scale: a self-report depression scale for research in the general population. Radloff LS, Applied Psychol Measure 1977 1 385 401 10.1177/014662167700100306
9. The center for epidemiologic studies depression scale: its use in a community sample. Roberts RE, Vernon SW, Am J Psychiatry 1983 140 41 46 6847983 (Pubitemid 13221717)
10. A new scale of depressive symptoms (in Japanese). Sima S, Kano T, Kitamura T, Asai M, Clinical Psychiatry 1985 27 717 723
11. Depression and the metabolic syndrome in young adults: findings from the third national health and nutrition examination survey. Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP, Psychosom Med 2004 66 316 322 10.1097/01.psy.0000124755.91880.f4 15184689 (Pubitemid 38668398)
12. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD project. Gil K, Radzillowicz P, Zdrojewski T, Pakalska-Korcala A, Chwojnicki K, Piwonski J, Ignaszewska-Wyrzykowska A, Zaluga L, Mielczarek M, Landowski J, et al. Kardiol Pol 2006 64 464 469 16752328
13. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 birth cohort study. Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M, Psychosom Med 2006 68 213 216 10.1097/01.psy.0000203172.02305.ea 16554385 (Pubitemid 43740123)
14. Associations between anxiety, depression, and the metabolic syndrome. Skilton MR, Moulin P, Terra JL, Bonnet F, Biol Psychiatry 2007 62 1251 1257 10.1016/j.biopsych.2007.01.012 17553465 (Pubitemid 350060887)
15. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW, Psychoneuroendocrinol 2007 32 151 159 10.1016/j.psyneuen.2006.11.009 (Pubitemid 46274017)
16. Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Akbaraly TN, Kivimaki M, Brunner EJ, Chandola T, Marmot MG, Singh-Manoux A, Ferrie JE, Diabetes Care 2009 32 499 504 10.2337/dc08-1358 19106378
17. Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Almeida OP, Calver J, Jamrozik K, Hankey GJ, Flicker L, Am J Geriatr Psychiatry 2009 17 889 898 10.1097/JGP. 0b013e3181b047e3 19910877
18. Association of the metabolic syndrome with depression and anxiety in Japanese men: a 1-year cohort study. Takeuchi T, Nakao M, Nomura K, Inoue M, Tsurugano S, Shinozaki Y, Yano E, Diabetes Metab Res Rev 2009 25 762 767 10.1002/dmrr.1041 19839027
19. Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study. Vanhala M, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H, Acta psychiatr Scand 2009 119 137 142 10.1111/j.1600-0447.2008.01283. x 19016666
20. Late-life depression, cortisol, and the metabolic syndrome. Vogelzangs N, Beekman AT, Dik MG, Bremmer MA, Comijs HC, Hoogendijk WJ, Deeg DJ, Penninx BW, Am J Geriatr Psychiatry 2009 17 716 721 10.1097/JGP.0b013e3181aad5d7 19625789
21. Depressive symptoms and metabolic syndrome in preventive healthcare: the cooper center longitudinal study. East C, Willis BL, Barlow CE, Grannemann BD, FitzGerald SJ, DeFina LF, Trivedi MH, Metab Syndr Relat Disord 2010 8 451 457 10.1089/met.2010.0017 20854094
22. Revisiting the association between metabolic syndrome and depressive symptoms. Kobrosly RW, van Wijngaarden E, Ann Epidemiol 2010 20 852 855 10.1016/j.annepidem.2010.08.002 20933192
23. Identifying depressive subtypes in a large cohort study: results from the Netherlands study of depression and anxiety (NESDA). Lamers F, de Jonge P, Nolen WA, Smit JH, Zitman FG, Beekman AT, Penninx BW, J Clin Psychiatry 2010 71 1582 1589 10.4088/JCP.09m05398blu 20673552
24. Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. Akbaraly TN, Ancelin ML, Jaussent I, Ritchie C, Barberger-Gateau P, Dufouil C, Kivimaki M, Berr C, Ritchie K, Diabetes Care 2011 34 904 909 10.2337/dc10-1644 21346185
25. Associations of psychological distress with metabolic syndrome among Japanese urban residents. Nishina M, Nishina K, Ohira T, Makino K, Iso H, J Atheroscler Thromb 2011 18 396 402 10.5551/jat.6692 21325777
26. Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. Vogelzangs N, Beekman AT, Boelhouwer IG, Bandinelli S, Milaneschi Y, Ferrucci L, Penninx BW, J Clin Psychiatry 2011 72 598 604 10.4088/JCP.10m06559 21535996
27. Prevalence of the metabolic syndrome in unipolar major depression. Kahl KG, Greggersen W, Schweiger U, Cordes J, Balijepalli C, Losch C, Moebus S, Eur Arch Psychiatry Clin Neurosci 2012 262 313 320 10.1007/s00406-011-0277-4 22183567
28. Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study. Seppala J, Vanhala M, Kautiainen H, Eriksson J, Kampman O, Mantyselka P, Oksa H, Ovaskainen Y, Viikki M, Koponen H, J Affect Disord 2012 136 543 549 10.1016/j.jad.2011.10.032 22119085
29. Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Pyykkonen AJ, Raikkonen K, Tuomi T, Eriksson JG, Groop L, Isomaa B, Ann Med 2012 44 279 288 10.3109/07853890.2010.543921 21254903
30. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W, Science 1984 226 1342 1344 10.1126/science.6334362 6334362 (Pubitemid 15215592)
31. Ketoconazole administration in hypercortisolemic depression. Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H, Am J Psychiatry 1993 150 810 812 8480829 (Pubitemid 23137691)
32. Co-occurring manic symptomatology influences HPA axis alterations in depression. Jabben N, Nolen WA, Smit JH, Vreeburg SA, Beekman AT, Penninx BW, J Psychiatr Res 2011 45 1208 1213 21450306
33. Role of stress in the pathogenesis of the metabolic syndrome. Rosmond R, Psychoneuroendocrinol 2005 30 1 10 10.1016/j.psyneuen.2004.05.007 (Pubitemid 39195039)
34. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP, J Clin Endocrinol Metab 2009 94 2692 2701 10.1210/jc.2009-0370 19470627
35. Perturbed autonomic nervous system function in metabolic syndrome. Tentolouris N, Argyrakopoulou G, Katsilambros N, Neuromolecular Med 2008 10 169 178 10.1007/s12017-008-8022-5 18224460
36. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. Licht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, DeRijk RH, Vogelzangs N, Zitman FG, de Geus EJ, Penninx BW, J Clin Endocrinol Metab 2010 95 2458 2466 10.1210/jc.2009-2801 20237163
37. Metabolic syndrome is associated with silent ischemic brain lesions. Bokura H, Yamaguchi S, Iijima K, Nagai A, Oguro H, Stroke 2008 39 1607 1609 10.1161/STROKEAHA.107.508630 18323475
38. White matter hyperintensities in late life depression: a systematic review. Herrmann LL, Le Masurier M, Ebmeier KP, J Neurol Neurosurg Psychiatry 2008 79 619 624 17717021 (Pubitemid 351829430)
39. Differential impact of lacunes and microvascular lesions on poststroke depression. Santos M, Gold G, Kovari E, Herrmann FR, Bozikas VP, Bouras C, Giannakopoulos P, Stroke 2009 40 3557 3562 10.1161/STROKEAHA.109.548545 19696424